N˚

Sex

Sickle cell disease

Background treatment

Basal haemoglobin

Malignant hemopathy

Age (years odl)

Treatment

Mortality

1

M

SS

HU

6.5

NHL

20

chemotherapy

On going

2

F

SS

HU

6.2

ALL 3

58

No one

Death (volution)

3

F

Sβ+

No one

10.5

CML

33

Tyrosine kinase inhibitor

Hematological remission

4

F

SC

No one

-

ALL T

12

chemotherapy

Death (consolidation)